Media MICE

What does it take to bring an optogenetic therapy toward clinical application?

At Eyecelerator, Samuel B. Barone, MD, of Nanoscope Therapeutics shares his perspective on the transformative potential of optogenetics and what gathering with fellow pioneers gives him to keep pushing forward.

​A closer look at an innovative approach to retinal disease, and the people working to bring it to patients.

Learn more at https://www.eyecelerator.com/

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

#Eyecelerator #Optogenetics #NanoscopeTherapeutics #GeneTherapy #Ophthalmology #EyeCare #MediaMICE #AAO2026